1-17331039-G-A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_012387.3(PADI4):c.163G>A(p.Gly55Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.574 in 1,607,640 control chromosomes in the GnomAD database, including 266,699 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.55 ( 23311 hom., cov: 32)
Exomes 𝑓: 0.58 ( 243388 hom. )
Consequence
PADI4
NM_012387.3 missense
NM_012387.3 missense
Scores
16
Clinical Significance
Conservation
PhyloP100: -1.24
Genes affected
PADI4 (HGNC:18368): (peptidyl arginine deiminase 4) This gene is a member of a gene family which encodes enzymes responsible for the conversion of arginine residues to citrulline residues. This gene may play a role in granulocyte and macrophage development leading to inflammation and immune response. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=1.2175569E-5).
BP6
?
Variant 1-17331039-G-A is Benign according to our data. Variant chr1-17331039-G-A is described in ClinVar as [Benign]. Clinvar id is 972892.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
?
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.579 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PADI4 | NM_012387.3 | c.163G>A | p.Gly55Ser | missense_variant | 2/16 | ENST00000375448.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PADI4 | ENST00000375448.4 | c.163G>A | p.Gly55Ser | missense_variant | 2/16 | 1 | NM_012387.3 | P1 | |
PADI4 | ENST00000375453.5 | c.163G>A | p.Gly55Ser | missense_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.551 AC: 83654AN: 151870Hom.: 23320 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
83654
AN:
151870
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.559 AC: 137546AN: 246090Hom.: 38920 AF XY: 0.563 AC XY: 74936AN XY: 133190
GnomAD3 exomes
AF:
AC:
137546
AN:
246090
Hom.:
AF XY:
AC XY:
74936
AN XY:
133190
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.577 AC: 839624AN: 1455652Hom.: 243388 Cov.: 36 AF XY: 0.576 AC XY: 417280AN XY: 724128
GnomAD4 exome
AF:
AC:
839624
AN:
1455652
Hom.:
Cov.:
36
AF XY:
AC XY:
417280
AN XY:
724128
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.551 AC: 83679AN: 151988Hom.: 23311 Cov.: 32 AF XY: 0.551 AC XY: 40952AN XY: 74292
GnomAD4 genome
?
AF:
AC:
83679
AN:
151988
Hom.:
Cov.:
32
AF XY:
AC XY:
40952
AN XY:
74292
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2174
ALSPAC
AF:
AC:
2279
ESP6500AA
AF:
AC:
2135
ESP6500EA
AF:
AC:
4958
ExAC
?
AF:
AC:
68108
Asia WGS
AF:
AC:
1682
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
PADI4-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Rheumatoid arthritis;C5441745:Abnormal pulmonary interstitial morphology Other:1
association, no assertion criteria provided | case-control | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | Feb 01, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationTaster
Benign
P;P
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.0
.;B
Vest4
MPC
0.11
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at